Pillstats
Rx only · Injection, Solution · Intravenous

Desmopressin Acetate

Desmopressin Acetate

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US17 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)3251
US makers9 labelers
Packages19
DEA / ScheduleNone

US acquisition costNADAC · per unit

Average across 11 priced NDCs. A benchmark of pharmacy acquisition cost — not a retail quote.

$6.00$12.00$17.99$23.99Dec 2025Apr 2026Jul 2026
$20.708
Latest avg · Jul 22, 2026
+17%
Since Dec 17, 2025
9
Active US suppliers
32%
Top-2 supplier share*

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1533064596122025 Q12025 Q22025 Q32025 Q42026 Q1
532
Rx · 2026 Q1
9.0K
Units dispensed
+22%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
SUN PHARMACEUTICAL INDUSTRIES, INC.unknown4SUPPLYING
Fresenius Kabi USA, LLCunknown2SUPPLYING
Avenacy, LLCunknown2SUPPLYING
Gland Pharma Limitedunknown2SUPPLYING
Armas Pharmaceuticals Inc.unknown2SUPPLYING
Sagent Pharmaceuticalsunknown2SUPPLYING
XGen Pharmaceuticals DJB, Inc.unknown2SUPPLYING
Caplin Steriles Limitedunknown2SUPPLYING
Dr.Reddy's laboratories Limitedunknown1SUPPLYING

Regulatory & supply events

No recalls, shortages, or registration changes on record for this drug concept.